Current Ratio of SAB Biotherapeutics, Inc. from 30 Sep 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
SAB Biotherapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2021 to 31 Dec 2025.
  • SAB Biotherapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 574%, a 31% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

SAB Biotherapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q4 2025 574% +136% +31% 31 Dec 2025
Q3 2025 416% -86% -17% 30 Sep 2025
Q2 2025 221% -193% -47% 30 Jun 2025
Q1 2025 330% +30% +10% 31 Mar 2025
Q4 2024 438% +245% +127% 31 Dec 2024
Q3 2024 502% +401% +398% 30 Sep 2024
Q2 2024 414% +294% +244% 30 Jun 2024
Q1 2024 300% +159% +113% 31 Mar 2024
Q4 2023 193% +31% +19% 31 Dec 2023
Q3 2023 101% -73% -42% 30 Sep 2023
Q2 2023 120% -66% -35% 30 Jun 2023
Q1 2023 140% -52% -27% 31 Mar 2023
Q4 2022 162% -35% -18% 31 Dec 2022
Q3 2022 174% -147% -46% 30 Sep 2022
Q2 2022 186% 30 Jun 2022
Q1 2022 193% 31 Mar 2022
Q4 2021 196% 31 Dec 2021
Q3 2021 321% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.